3AJ-18167-62623
3 vaccinations
5 coded responses
31 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 921 / CA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-26
- 2020-12-28
- 2021-01-04
-
2021-01-11
Survey response — day 21, dose 1MedDRA: Fatigue, Headache, Oropharyngeal pain, Pregnancy — Feeling: Good · Be unable to do your normal daily activitiesFree text: Had fatigue, mild headache and mild sore throat over the weekend, not sure if due to pregnancy, fatigue from stressful work week, or other reason.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — day 21, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Dose 2 — Pfizer-BioNTech
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-13
- 2021-02-19
- 2021-02-26
- 2021-04-16
- 2021-07-16
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Lymph node swelling in axilaMedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: GoodFree text: Swelling in axila on side of injectionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph nodes in axila on injection sideMedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-26
- 2021-11-01
- 2021-11-08
- 2021-11-17
- 2021-12-27
-
2022-03-28
Survey response — 6 months, dose 3MedDRA: Malaise — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID symptoms, now resolved.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-11 | Unsuccessful | |
| 2021-09-29 | Unsuccessful |
Free text
Release 1 — day 21, dose 1
Symptoms: Had fatigue, mild headache and mild sore throat over the weekend, not sure if due to pregnancy, fatigue from stressful work week, or other reason.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Lymph node swelling in axila
Systemic reaction (other): Swelling in axila on side of injection
Systemic reaction (other): Swollen lymph nodes in axila on injection side
Release 11 — 6 months, dose 3
Symptoms: COVID symptoms, now resolved.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Maternal exposure during pregnancy | ○ | ○ | ○ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release